Sodium Glucose Cotransporter Inhibition in Acute Heart Failure: An In-Depth Review
Inhibitors of the sodium glucose cotransporters were initially developed for the treatment of type 2 diabetes but have since been shown to provide many benefits in heart failure, especially in heart failure with reduced ejection fraction (HFrEF). Already an established and foundational therapy for H...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2025-04-01
|
| Edice: | CJC Open |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2589790X2400653X |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|